Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05381610 · ClinicalTrials.gov registry record · NA
A Clinical Investigation Evaluating Peristeen® Performance
A NA study, sponsored by Coloplast A/S.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05381610 is a NA study that was terminated before completion, run by Coloplast A/S. The registered enrollment target is 6 participants.
The verdict
NCT05381610, a NA study, was terminated before completion, sponsored by Coloplast A/S.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Peristeen has been on the market globally since 2006 and marketed in the US since 2012, and more than 10,000 patients worldwide have been using Peristeen, with over 3,000 patients in the US. However, the US reimbursement is not uniform, resulting in many patients suffering from NBD in sub-optimal bowel manage-ment. Therefore, this study will scientifically define and describe how the Peristeen system is different from a large volume enema.
Interventions
- DEVICE Peristeen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2024-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05381610
The ClinicalTrials.gov registry entry for NCT05381610 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Peristeen is the first listed.
NCT05381610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05381610 about?
NCT05381610 is a clinical study titled "A Clinical Investigation Evaluating Peristeen® Performance". Peristeen has been on the market globally since 2006 and marketed in the US since 2012, and more than 10,000 patients worldwide have been using Peristeen, with over 3,000 patients in the US. However, the US reimbursement is not uniform, resulting in many patients suffering from NBD in sub-optimal bo...
What is the current status of trial NCT05381610?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2022-06-01. Estimated completion is 2024-02-13.
What interventions are being tested in trial NCT05381610?
The interventions under investigation include: Peristeen (DEVICE).
Who is sponsoring clinical trial NCT05381610?
This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.